Literature DB >> 6873772

Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriers.

B Ríhová, K Ulbrich, J Kopecek, P Mancal.   

Abstract

After repeated i.p. immunizations of mice with 10 micrograms of homopolymer poly (HPMA) no antibodies were detected by the ELISA test. Immunization with copolymer P-Acap-Leu-HMDA leads to a weak antibody response, while immunization with a copolymer with some side chains modified with ARS or FITC groups (P-Acap-Leu-HMDA-ARS or P-Acap-Leu-HMDA-FITC) leads to a significant antibody response detectable by PFC, ELISA and haemagglutination tests. Most of these antibodies are aimed against the modifying haptenic group, a smaller amount against side oligopeptide sequences of the carrier. Intensity of the antibody response depends on: 1) the antigen dose--the optimal dose was 10 micrograms: both the higher (100 micrograms) and the lower doses (1 and 0.1 micrograms) induced considerably lower antibody responses; 2) molar mass of the immunizing fractions--fractions of high molar mass induced up to five times higher responses than those of a low molar mass; 3) the bound haptenic group--the ARS-copolymers induced ten times lower response than the FITC-copolymers. We detected no difference between capacities of the H-2a, H-2b and H-2d haplotypes to react with anti-ARS antibodies after immunization with P-Acap-Leu-HMDA-ARS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873772     DOI: 10.1007/bf02884085

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  18 in total

1.  Azoproteins. I. Spectrophotometric studies of amino acid azo derivatives.

Authors:  M TABACHNICK; H SOBOTKA
Journal:  J Biol Chem       Date:  1959-07       Impact factor: 5.157

2.  ESTIMATION OF THE INDUCTIVE PHASE OF ANTIBODY FORMATION BY PLAQUE TECHNIQUE.

Authors:  J STERZL; L MANDEL
Journal:  Folia Microbiol (Praha)       Date:  1964-05       Impact factor: 2.099

Review 3.  Antigenicity: some molecular aspects.

Authors:  M Sela
Journal:  Science       Date:  1969-12-12       Impact factor: 47.728

4.  Induction of immunity and immunologic paralysis in mice against polyvinyl pyrrolidone.

Authors:  B Andersson
Journal:  J Immunol       Date:  1969-05       Impact factor: 5.422

5.  Detection of mouse cells producing antibodies against the azophenylarsonic group by haemolytic plaque assay.

Authors:  B Ríhová; H Tlaskalová; I Riha
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Enzyme immunoassay ELISA and EMIT.

Authors:  E Engvall
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Detection of cells producing 7S antibodies by the plaque technique.

Authors:  J Sterzl; I Ríha
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

8.  Genetic regulation of antibody response to sheep red blood cells: isoelectric focusing analysis of sera of well responding strain A/J and poorly responding strain B10 mice.

Authors:  B Ríhová; I Ríha
Journal:  Am J Reprod Immunol       Date:  1981-08       Impact factor: 3.886

9.  Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system.

Authors:  R Duncan; P Rejmanova; J Kopecek; J B Lloyd
Journal:  Biochim Biophys Acta       Date:  1981-11-18

10.  Asimple test for immunogenicity of colloidal infusion solutions- the draining lymph node activation.

Authors:  L Korcáková; E Paluska; V Hasková; J Kopecek
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1976-04
View more
  11 in total

1.  HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.

Authors:  Sarita Rani; Avinash Gothwal; Pawan K Pandey; Devendra S Chauhan; Praveen K Pachouri; Umesh D Gupta; Umesh Gupta
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

Review 2.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

3.  Immunogenicity of coiled-coil based drug-free macromolecular therapeutics.

Authors:  Miloslav Kverka; Jonathan M Hartley; Te-Wei Chu; Jiyuan Yang; Regina Heidchen; Jindřich Kopeček
Journal:  Biomaterials       Date:  2014-04-22       Impact factor: 12.479

Review 4.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 5.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

6.  Intracellular trafficking and subcellular distribution of a large array of HPMA copolymers.

Authors:  Jon Callahan; Pavla Kopečkov; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2009-05-21       Impact factor: 6.988

7.  Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization.

Authors:  Jon Callahan; Jindrich Kopecek
Journal:  Biomacromolecules       Date:  2006-08       Impact factor: 6.988

Review 8.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 9.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

10.  HPMA copolymers: origins, early developments, present, and future.

Authors:  Jindrich Kopecek; Pavla Kopecková
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.